Cresset is attending EFMC-ISMC 2026 in Basel next week at Stand 10 to hear about developments and drug discovery.

Cresset® is revolutionizing molecule design and cross-team communication, combining cutting-edge science with AI/ML to enable our customers to discover new compounds faster and more efficiently. Chemists in the world’s leading research organizations use Cresset solutions to discover, design, optimize, synthesize and track the best small molecules. By integrating their in silico CADD and DMTA discovery solutions with Cresset’s first-class discovery research resources, researchers will have access to patented CADD Software, collaborative Torx® DMTA platform and expert Discovery CRO scientists. In helping organizations reach better design and synthesis decisions faster and more efficiently, we enable them to win the race to success in industries including: pharmaceuticals, agrochemicals, flavors and fragrances.